HopeStage
Back to all studies
CompletedNCT02418195

Blood Markers Related to Suicidal Thoughts and Ketamine Treatment

About this title

miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome

Read the official source — NCT02418195
Medication studyAges 18–65United StatesSuicide prevention
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
BirminghamSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 20, 2015
Recruitment status
Completed
Enrollment listed in the registry
247
Sponsor
University of Alabama at Birmingham
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT02418195
Official title
Show the full official title

Plasma Exosomal MicroRNAs as Promising Novel Biomarkers for Suicidality and Treatment Outcome

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Alabama at Birmingham, a university.

Did this study involve medication?

Yes. The study involved medication, including ketamine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies